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Available online xxxxBackground: Cementless unicondylar knee arthroplasty (UKA) was introduced to secure long-
term ﬁxation and reduce the risk of revision. Experience with cementless UKA ﬁxation is limited.
Methods: The short-term survival (up to ﬁve years) of cementless Oxford UKA was assessed
using data from the Finish Arthroplasty Register and was compared with that of cemented
Oxford 3 UKA and total knee arthroplasty (TKA). Datawere obtained, from the Finnish
Arthroplasty Register, on 1076 cementless Oxford UKAs and 2279 cemented Oxford 3 UKAs
performed for primary osteoarthritis in 2005-2015. The Kaplan-Meier method, with revision
for any reason as the endpoint, was used to assess the survival of these two UKA groups,
and the results were compared with that of 65,563 cemented TKAs treated for primary osteo-
arthritis over the same period. The risk of revision of both Oxford prostheses was compared
using Cox regression model, with adjustment for age and sex, with the cemented TKA group
as reference.
Results: The three-year survivalwas 93.7% for the cementless Oxford, 92.2% for the cementedOxford
3, and 97.3% for the cemented TKA. The corresponding ﬁgures at ﬁve years were 92.3%, 88.9%, and
96.6%, respectively. The revision rate for both the cementless Oxford and the cemented Oxford 3
was signiﬁcantly increased when compared with the cemented TKA (P b 0.001).
Conclusions: The survival of the cementless Oxford method was higher than that of the cemented
Oxford 3 in the short term. The overall survival of Oxford UKA was poor in comparison with
contemporary TKAs.
© 2019 Elsevier B.V. All rights reserved.Keywords:
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Total knee arthroplasty (TKA) is the gold standard for treatment of symptomatic osteoarthritis (OA) of the knee when conservative
treatment is insufﬁcient. In addition to TKA, unicompartmental knee arthroplasty (UKA) can be used to treat OAwhen it is conﬁned to a
single compartment. Medial UKA may have some advantages over TKA (e.g. faster recovery, reduced perioperative morbidity and
mortality, subjective preference for a more normal-feeling knee, lower cost, and more rapid return to work and sport) [1,2].ics and Traumatology, Turku University Hospital, Luolavuorentie 2, 20700 Turku, Finland.
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2 J. Knifsund et al. / The Knee xxx (xxxx) xxxThe standard method of ﬁxation for UKA is cementation. Cemented UKAs are commonly performed using a minimally invasive
technique; however, this is a challenging procedure since cementation errors may lead to loosening, pain, and excess wear [3].
Cementation of unicompartmental prostheses may be especially problematic compared with TKA because the medial tibial
bone is often very sclerotic and suboptimal for cementing. In TKA, cemented ﬁxation adheres not only to medial but also to
the cancellous lateral tibial bone tissue, which enhances ﬁxation.
Analyses of data in arthroplasty registers from Finland, Sweden, Australia, New Zealand, and the United Kingdom have repeatedly
reported inferior survival of cemented UKAs compared with cemented TKAs [4–9]. Consequently, cementless UKAwas introduced to
secure long-term ﬁxation and reduce the risk of revision. So far, the experience with cementless ﬁxation in UKAs has been rather
limited. Nevertheless, several reports over the recent ﬁve to 10 years have claimed that cementless UKAs may be associated with
good clinical and radiological outcomes, and that cementless implantsmay have some advantages over cemented implants [3,10–13].
The Oxford implant is the most common cemented UKA design. It has a congruent mobile bearing to minimise wear (Zimmer
Biomet, UK) [4,7]. A cementless version of the Oxford has been introduced; it has a porous titanium and calcium hydroxyapatite
coating. According to data from the New Zealand registry, implant survival of the cementless Oxford version is higher than that of
the cemented Oxford 3 version [8].
The cementless Oxford version is currently the market leader in Finland [5]. The aim of this study was to assess the short-term
survival of the cementless Oxford UKA device on the basis of data from the Finnish Arthroplasty Register (FAR), and to compare
its survival with those of the cemented Oxford 3 UKA and cemented TKA reference group. Short-term was deﬁned as a time span
of up to ﬁve years.
2. Patients and methods
The FAR has collected information on total joint replacements since 1980 [14]. Orthopaedic units are obliged to provide all
information that is essential for the maintenance of the register to the Finnish National Institute for Health and Welfare. Dates
of death are obtained from the Population Information System maintained by the Population Register Centre. Data capture of
the FAR is high when compared with that of the Hospital Discharge Register [5]. The FAR data for 2005–2017 are currently
based on implant catalogue numbers, and therefore cementless and cemented Oxford devices are able to be separately assessed.
For this study, data from 1076 cementless Oxford UKAs, 2279 cemented Oxford 3 UKAs, and 65,563 cemented TKAs indicated
for the treatment of primary OA in Finland during 2005–2015 were included. All data were gathered from the FAR database. The
TKA reference group consisted of the three most common brands used in Finland: Triathlon Cruciate Retaining (CR) (Stryker,
Mahwah, NJ), Nexgen ﬂex CR (Zimmer Biomet, Warsaw, IN), and PFC Sigma CR (DePuy, Warsaw, IN). There were 252 bilateral
Oxford 3, 130 bilateral cementless Oxford, and 11,287 bilateral TKA implants.
2.1. Statistics
Crude implant survival of the cementless Oxford, cemented Oxford 3, and cemented TKA control group was assessed using
Kaplan–Meier analysis. The Cox regression model was used to assess the differences in the revision rates of the devices and to adjust
for any confounding factors. In the Coxmodel, the reference groupwas the cemented TKA. Both UKA groupswere comparedwith the
reference group. Revisions were linked to the primary operation through the personal identiﬁcation numbers. The survival endpoint
was deﬁned as the revision, when either any of the components or the entire implant was removed or exchanged. The ﬁrst revision
for any reason served as an endpoint. Kaplan–Meier survival data were used to construct the crude survival probabilities of the
implants, with 95% conﬁdence interval (95% CI). Patients who died during the follow-up period (until December 31 2015) were
not included. Factors studied with the Cox model were age groups b55 years and ≥55 years, and sex.
The proportional hazards assumption of the Coxmodelswas checked by inspecting the Kaplan–Meier graphs. The survival rates of
the Oxford implants intersected at approximately 18 months of follow-up. For the Cox analyses comparing the cementless Oxford,
the cemented Oxford 3, and the cemented TKA reference group, the total follow-up timewas divided into the following two periods:
0–18 months and N18 months, because the proportional hazards assumptionwas not fulﬁlled for the total follow-up. For the shorter
follow-up, the knees with a follow-up N18 months and for the longer time period, the knees with a follow-up of b18 months were
excluded from the analyses.
The inclusion of bilateral cases in a survival analysis violates the basic assumption that all cases are independent. However,
several reports have shown that the effect of including bilateral cases in studies of hip and knee joint prosthesis survival, as per-
formed in the current study, is negligible [15,16]. The Wald test was used to test the estimated hazard ratios. The between-group
differences were considered to be statistically signiﬁcant if the P-values were b0.05 in a two-tailed test.
3. Results
Demographic data are shown in Table 1. The main reason for revision was ‘other reason/missing data’ for all study groups: 31%
for cementless Oxford, 58% for cemented Oxford 3, and 42% for the cemented TKA reference group (Table 2). The main reason for
the revision of the diagnoses that were available was ‘insert dislocation’ for the cementless Oxford method (16%), ‘aseptic loosen-
ing of the tibial component’ for the cemented Oxford 3 procedure (10%), and ‘infection’ for the cemented TKA reference group
(21%).Please cite this article as: J. Knifsund, A. Reito, J. Haapakoski, et al., Short-term survival of cementless Oxford unicondylar knee
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Table 1
Demographic data for cementless Oxford, cemented Oxford 3, and cemented total knee arthroplasty.
Demographic Cementless Oxford Cemented Oxford 3 Cemented TKA
N
Bilateral, n
1076
130
2279
252
65,563
11,287
Follow-up, years
Mean 2.7 7.4 4.9
Minimum 0.05 0.05 0.003
Maximum 7.8 11.7 11.7
Median 2.1 7.9 4.5
Males, % 44.1 39.1 34.7
Age, mean (SD) 61.5 (9.3) 62.1 (9.6) 68.4 (9.3)
Implanting period 2008–2015 2005–2014 2005–2015
Year 2005, n 0 334 1920
Year 2006, n 0 413 3081
Year 2007, n 0 382 4972
Year 2008, n 1 338 5434
Year 2009, n 15 275 5792
Year 2010, n 79 233 6322
Year 2011, n 90 188 6430
Year 2012, n 113 106 7550
Year 2013, n 142 9 7916
Year 2014, n 257 1 7919
Year 2015, n 379 0 8227
Number of hospitals 20 46 64
TKA, total knee arthroplasty; SD, standard deviation; n, number.
3J. Knifsund et al. / The Knee xxx (xxxx) xxxThe three-year survival was 93.7% (95% CI 92.1–95.4) for the cementless Oxford method, 92.2% (95% CI 91.1–93.3) for
cemented Oxford 3, and 97.3% (95% CI 97.1–97.4) for the cemented TKA reference group (Table 3, Figure 1). The three-year
survival of the cementless UKA and cemented UKA was the same (conﬁdence limits were overlapping). The ﬁve-year survival
of the cementless UKA was signiﬁcantly higher compared to that of the cemented UKA (no overlap of the conﬁdence limits).
The corresponding ﬁgures at ﬁve years were 92.3% (95% CI 90.3–94.4), 88.9% (95% CI 87.6–90.2), and 96.6% (95% CI 96.4–96.7)
(Table 3, Figure 1).
The adjusted overall revision rate of the cemented Oxford 3 was 3.0 (95% CI 2.7–3.4, P b 0.001) and of cementless Oxford 2.1
(95% CI 1.6–2.7, P b 0.001) compared with that of the cemented TKA reference group. During the ﬁrst 18 months, the adjusted
revision rate of the cemented Oxford 3 was 3.7 (95% CI 3.4–4.2, P b 0.001) and of the cementless Oxford 1.7 (95% CI 1.3–2.2,
P b 0.001) compared with the reference group. In the N18-month follow-up group, the adjusted revision rate of the cemented
Oxford 3 was 3.7 (95% CI 3.2–4.2, P b 0.001) and of the cementless Oxford 1.9 (95% CI 1.2–3.0, P = 0.006) compared with the
reference group (Table 4).
4. Discussion
It was found that the short-term survival of the cementless Oxford method was higher than that of the cemented Oxford 3
method. Also, the overall survival of both UKA types was inferior to that of cemented TKAs.
It is acknowledged that this study had some limitations. First, as is common in register-based studies, implant survival was the
only outcome that was able to be assessed. Patient-reported outcome measures were not included in the available data on FARTable 2
Reasons for revision.
Reason for revision Cementless Oxford
n (%)
Cemented Oxford 3
n (%)
Cemented TKA reference group
n (%)
Insert dislocation 10 (16%) 10 (3%) 19 (1%)
Aseptic loosening of tibial component 8 (13%) 35 (10%) 50 (2%)
Malposition 7 (11%) 15 (4%) 145 (7%)
Fracture 6 (9%) 2 (1%) 46 (2%)
Pain only 6 (9%) 23 (7%) 150 (7%)
Infection 3 (5%) 12 (4%) 434 (12%)
Instability 3 (5%) 14 (4%) 171 (8%)
Aseptic loosening of femoral component 1 (2%) 27 (8%) 64 (3%)
Implant breakage 0 (0%) 1 (0%) 1 (0%)
Patellofemoral arthrosis progressing 0 (0%) 6 (2%) 113 (5%)
Stiffness 0 (0%) 0 (0%) 12 (1%)
Other reason or missing data 20 (31%) 197 (58%) 889 (42%)
All 64 (100%) 342 (100%) 2094 (100%)
TKA, total knee arthroplasty.
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Table 3
Kaplan–Meier survival of cementless Oxford, cemented Oxford 3, and cemented total knee arthroplasty reference at three and ﬁve years. Kaplan–Meier survival of
cemented Oxford 3 and cemented total knee arthroplasty reference group at 10 years are also presented.
Implant type 3 year 5 year 10 year
At risk Survival %
(95% CI)
At risk Survival %
(95% CI)
At risk Survival %
(95% CI)
Cementless Oxford 365 93.7
(92.1–95.4)
149 92.3
(90.3–94.4)
– –
Cemented Oxford 3 2077 92.2
(91.1–93.3)
1826 88.9
(87.6–90.2)
466 82.6
(80.8–84.5)
Cemented TKA reference group 44,560 97.3
(97.1–97.4)
28,801 96.6
(96.4–96.7)
3308 95.3
(95.1–95.6)
CI, conﬁdence interval; TKA, total knee arthroplasty.
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subjective preference for a more normal-feeling knee than TKA patients, but these matters were not addressed in the current study.
Second, data regarding the patients' medical histories, comorbidities, and knee radiographs were not available. Comparing UKA
results with TKA results is complicated. Even if patients were matched for age and sex, the characteristics of patients undergoing UKA
and TKA may be quite different. In general, patients undergoing UKA may be more active and have higher expectations after surgery.
Third, surgeon level data were not available in the FAR. Surgical volume is an important predictor of success after UKA.
Surgeons performing ≤12 UKAs per year (i.e. most surgeons) have a double rate of revision compared with surgeons performing
N12 UKAs per year [17]. The relationship between the popularity of UKA and revision rate is complex and non-linear. Statistically,
the results are optimal when between 40 and 60% of all arthroplasties are UKAs. Surgeons who perform the fewest UKAs (up to
ﬁve percent of all arthroplasties) have the highest revision rates [18]. The UKA procedures included in the current study may have
been performed by low-volume surgeons, which would explain the overall high revision rate of UKA in this study.
Before revision of the FAR register, which was completed in May 2014, the accuracy of reporting the indications for revision
in FAR was poor. The National Institute for Health and Welfare has been responsible for managing FAR since December 2009,
and guidance from the Orthopedic Society may have been insufﬁcient. Older data were not appropriate for a precise assessment
of the indications for arthroplasty revisions. Furthermore, check-ups for missing data were not systematically performed, and
hospitals were not informed if there were any data shortages. For these historical reasons, 31% of the indications for revisions
of the cementless Oxford UKA were coded for the current study either as other reasons or missing data. The proportion of
other reason/missing data was even higher for the cemented Oxford 3 UKA and the cemented TKA reference group. Thus, assess-
ment of the indications for revisions was incomplete for reasons related to insufﬁcient registry data. Overall, data on primary and
revision TKA in FAR is very comprehensive and thus almost all primary TKAs and most revision TKAs have been reported to FAR,
as shown by comparison with the data in the National Discharge Register. Data on primary TKAs covered 95% and on revisions
85% of all procedures performed in Finnish hospitals during this study period (2005–2015) [5].Figure 1. Kaplan–Meier survival of cementless Oxford, cemented Oxford 3, and cemented total knee arthroplasty reference group.
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Table 4
Adjusted revision risk (age, sex) for revision of any reason for cementless Oxford and cemented Oxford 3, cemented total knee arthroplasty as the reference group.
Implant type Follow-up
Overall
Follow-up
0–18 months
Follow-up
N18 months
RR
(95% CI)
P RR
(95% CI)
P RR
(95% CI)
P
Cemented TKA 1 – 1 – 1 –
Cemented Oxford 3 3.0
(2.7–3.4)
b0.001 3.7
(3.4–4.2)
b0.001 3.7
(3.2–4.2)
b0.001
Cementless Oxford 2.1
(1.6–2.7)
b0.001 1.7
(1.3–2.2)
b0.001 1.9
(1.2–3.0)
b0.006
RR, revision risk; TKA, total knee arthroplasty; CI, conﬁdence interval.
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size. The complete follow-up of the study population limited the possibility of selection bias risk that is associated with register
studies.
According to the New Zealand Registry with data from 2000 to 2017, the revision rate of 3862 cementless Oxfords per 100
component years was 0.76 (0.63–0.91), whereas that of 4080 cemented Oxford 3 procedures was 1.38 (1.26–1.50) [8]. The
current ﬁndings support these ﬁndings, although component years was not used in reporting. It seems that the short-term
implant survival of the cementless Oxford method has really improved when compared to that of the cemented Oxford 3 proce-
dure. However, at least in Finland, the use of the cemented Oxford 3 has ended, and in 2015 all UKAs were cementless Oxfords
(Table 1). Thus, the era when cemented and cementless Oxfords were implanted is not the same. Overall, the indications for UKA
surgery have become more stringent. It has been well established that symptomatic patients who have radiologically mild OA
have an increased risk of revision [19,20]. When indications became more stringent, the need of ‘unnecessary’ revisions (for
pain alone) may decrease. Finland has been systematically educating surgeons to consider the fact that preoperative radiological
OA grade must be bone-to-bone in UKA surgery. These circumstances have probably increased the survival of the cementless
Oxford device in comparison with the cemented one in Finland.
According to Australian Orthopaedic AssociationNational Joint Replacement Registry (AOANJRR) data, the 10-year cumulative re-
vision frequency of the cemented Oxford 3 implant is 14.8% and of the cementless Oxford implant 13.6% [4]. The equivalent 10-year
Kaplan–Meier estimate of the cumulative percentage probability of ﬁrst revision in England and Wales for the Oxford 3 implant is
11.4% [7], and in Sweden 13% [9]. Current data corroborate these ﬁndings, although the revision rate of the cemented Oxford 3
implant is slightly higher in Finland than in other countries.
Implant survival of ﬁxed bearing UKAs may be increased when compared with that of mobile bearing UKAs like the Oxford,
since bearing dislocations are not possible with the former implant. The 10-year Kaplan–Meier estimate of the cumulative
frequency of revision in England and Wales of ﬁxed bearing UKAs is 9.9% compared with 11.8% of mobile bearing UKAs [7].
According to AOANJRR data, the 10-year cumulative percent revision of ZUK (Zimmer Biomet, UK) ﬁxed bearing UKA was 8.6%
of 6785 UKAs [4]. According to the New Zealand Registry, the revision rate of 1328 ZUK ﬁxed bearing UKAs per 100 component
years is 0.52 (0.33–0.76) [8]. These data are encouraging for ﬁxed bearing UKAs and especially for ZUK, which is the current
market leader of ﬁxed bearing UKAs in the named countries. Since ﬁxed bearing UKA data are not available in the FAR, the current
situation in Finland is unknown.
Based on the New Zealand Joint Registry (NZJR), the most common reasons for UKA revisions are pain, loosening of a tibial
component, and loosening of a femoral component [8]. The indications for revisions of the cementless Oxford implant have not
been separately assessed [8]. Twenty-three tibial fractures were reported to the NZJR, but it is unknown whether these cases
were related to the use of cementless UKAs or not. Six tibial fractures associated with the use of the cementless Oxford implant
have been reported to FAR thus far (nine percent of all revisions, 0.5% of all operations). It seems that the risk of a perioperative
tibial fracture when using the cementless Oxford method is small, although higher than with the cemented Oxford 3 implant (one
percent of all revisions, 0.0009% of all operations). Due to the poor accuracy of reported indications for revision to the FAR, the
true incidence of perioperative fractures may be higher.
In a systematic literature review of 10 papers (1199 knees) on the outcome of cementless UKA, there were 48 revisions,
with an overall revision rate of 0.8 per 100 observed component-years. The most common cause of failure was progression
of OA in the retained component (11 revisions, 0.9% of all operations), followed by bearing dislocation (eight revisions,
0.7% of all operations), and loosening of the tibial component (six revisions, 0.4% of all operations) [21]. Progression of OA
in the lateral component is a major reason for UKA failure in the longer term. However, the follow-up time after implantation
of the cementless Oxford device in the current study was short when compared with the review (median 2.1 years in the cur-
rent study, median ﬁve years in the review). Furthermore, progression of lateral OA was, unfortunately, not separately
assessed as a reason for revision in the current FAR data contents. This ﬂaw will be revised in the following FAR data contents
update. Based on the review data, periprosthetic tibial fractures are an uncommon complication of cementless UKA surgery
[21]. However, these data were from specialised clinics only. Data from the current study were population-based and in-
cluded all UKA surgeons in Finland, which partially invalidated the comparison. Therefore, the overall revision rate in this
population-based study (64 revisions, 1076 cementless Oxfords) was slightly higher than in the review (48 revisions, 1199
cementless UKAs).Please cite this article as: J. Knifsund, A. Reito, J. Haapakoski, et al., Short-term survival of cementless Oxford unicondylar knee
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was 83% (approximated from the ﬁgure) [6]. These earlier data are in accordance with the current results based on 2005–2015
data. However, in an earlier report, it was not possible to separately assess cementless and cemented Oxfords. The popularity
of the cementless Oxford method markedly grew after publication of the previous study in 2014 [6]; therefore, reporting implant
survival of both ﬁxation methods mixed with an earlier study was probably unbiased. The most common reason for revision in
the earlier study based on FAR data was ‘aseptic loosening’ (46.8%), followed by ‘other reason’ (35%). Although the accuracy of
recording reasons for revision in the FAR registry was unsatisfactory, it seems that aseptic loosening as a major cause of failure
of the cementless Oxford implant has decreased in Finland.
To conclude, in the short term, use of the cementless Oxford implant is associated with increased survival compared with the
cemented Oxford 3. However, overall survival of both UKA types is still inferior to contemporary cemented TKAs.Conﬂict of interest
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